Swedes publish registration fees for IVDs (in vitro diagnostics):
This article was originally published in Clinica
Executive Summary
The Swedish National Board of Health and Welfare has published its registration fees for in vitro diagnostics as part of its transposition of the IVD Directive. The fees range from SKr 500 ($56.2) for up to 10 products to SKr 5,000 for over 500 products. There will also be a registration fee of SKr 1,000 per manufacturer or authorised representative. All CE-marked IVDs will have to be registered in Swedish or English before they can be marketed. Information for the end-user must be in Swedish. The classification has to be in accordance with the European Diagnostics Manufacturers Association classification, until the global medical device nomenclature system is published.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.